Logo image of NRC

NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD

15.72  -0.45 (-2.78%)

After market: 15.72 0 (0%)

Fundamental Rating

5

Overall NRC gets a fundamental rating of 5 out of 10. We evaluated NRC against 104 industry peers in the Health Care Providers & Services industry. While NRC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NRC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

NRC had positive earnings in the past year.
In the past year NRC had a positive cash flow from operations.
NRC had positive earnings in each of the past 5 years.
Each year in the past 5 years NRC had a positive operating cash flow.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

NRC has a better Return On Assets (17.91%) than 100.00% of its industry peers.
NRC has a Return On Equity of 81.59%. This is amongst the best in the industry. NRC outperforms 99.04% of its industry peers.
NRC's Return On Invested Capital of 26.72% is amongst the best of the industry. NRC outperforms 95.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NRC is significantly above the industry average of 9.61%.
The 3 year average ROIC (37.15%) for NRC is well above the current ROIC(26.72%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 17.91%
ROE 81.59%
ROIC 26.72%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

1.3 Margins

NRC has a better Profit Margin (17.13%) than 99.04% of its industry peers.
In the last couple of years the Profit Margin of NRC has declined.
NRC's Operating Margin of 24.89% is amongst the best of the industry. NRC outperforms 97.12% of its industry peers.
NRC's Operating Margin has declined in the last couple of years.
NRC's Gross Margin of 60.27% is amongst the best of the industry. NRC outperforms 82.69% of its industry peers.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
Industry RankSector Rank
OM 24.89%
PM (TTM) 17.13%
GM 60.27%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NRC is creating value.
NRC has less shares outstanding than it did 1 year ago.
NRC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NRC has a worse debt to assets ratio.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

NRC has an Altman-Z score of 3.73. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
NRC's Altman-Z score of 3.73 is fine compared to the rest of the industry. NRC outperforms 71.15% of its industry peers.
The Debt to FCF ratio of NRC is 4.37, which is a neutral value as it means it would take NRC, 4.37 years of fcf income to pay off all of its debts.
NRC has a Debt to FCF ratio of 4.37. This is in the better half of the industry: NRC outperforms 75.96% of its industry peers.
NRC has a Debt/Equity ratio of 2.10. This is a high value indicating a heavy dependency on external financing.
NRC has a worse Debt to Equity ratio (2.10) than 75.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 4.37
Altman-Z 3.73
ROIC/WACC3.21
WACC8.32%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.54 indicates that NRC may have some problems paying its short term obligations.
The Current ratio of NRC (0.54) is worse than 89.42% of its industry peers.
A Quick Ratio of 0.54 indicates that NRC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.54, NRC is doing worse than 86.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

NRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.26%.
The Earnings Per Share has been decreasing by -3.70% on average over the past years.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -4.08% in the last year.
Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 2.25% on average per year.
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.42, NRC is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 66.35% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.85, NRC is valued a bit cheaper.
Industry RankSector Rank
PE 20.42
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 66.35% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, NRC is valued a bit cheaper than the industry average as 60.58% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.31
EV/EBITDA 10.48
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

NRC has a Yearly Dividend Yield of 3.20%.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.91. NRC pays more dividend than 93.27% of the companies in the same industry.
NRC's Dividend Yield is a higher than the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 3.2%

5.2 History

The dividend of NRC decreases each year by -17.40%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

NRC pays out 46.75% of its income as dividend. This is a bit on the high side, but may be sustainable.
The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP46.75%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

More info and screens

NATIONAL RESEARCH CORP

NASDAQ:NRC (8/20/2025, 4:30:01 PM)

After market: 15.72 0 (0%)

15.72

-0.45 (-2.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-05 2025-08-05
Earnings (Next)10-27 2025-10-27
Inst Owners50.59%
Inst Owner Change0.15%
Ins Owners9.49%
Ins Owner Change10.89%
Market Cap363.13M
Analysts45
Price TargetN/A
Short Float %3.17%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 3.2%
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP46.75%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-26 2025-09-26 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.42
Fwd PE N/A
P/S 2.57
P/FCF 24.31
P/OCF 12.42
P/B 12.24
P/tB N/A
EV/EBITDA 10.48
EPS(TTM)0.77
EY4.9%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.65
FCFY4.11%
OCF(TTM)1.27
OCFY8.05%
SpS6.12
BVpS1.28
TBVpS-1.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.91%
ROE 81.59%
ROCE 36.11%
ROIC 26.72%
ROICexc 27.4%
ROICexgc 90.7%
OM 24.89%
PM (TTM) 17.13%
GM 60.27%
FCFM 10.57%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score5
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 4.37
Debt/EBITDA 1.51
Cap/Depr 233.71%
Cap/Sales 10.12%
Interest Coverage 13.06
Cash Conversion 70.8%
Profit Quality 61.7%
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z 3.73
F-Score5
WACC8.32%
ROIC/WACC3.21
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.46%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.79%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-18.18%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%